Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer.
about
Reduction in saturated fat intake for cardiovascular diseaseEffects of total fat intake on body weightReduced or modified dietary fat for preventing cardiovascular diseaseReduced or modified dietary fat for preventing cardiovascular diseaseReducing the Risk of Breast Cancer Recurrence: an Evaluation of the Effects and Mechanisms of Diet and ExerciseWeight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancerAssociations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancerMetabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapyMedical comorbidities predict mortality in women with a history of early stage breast cancer.Amelioration of sexual adverse effects in the early breast cancer patientFavorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obeseWeight, physical activity, diet, and prognosis in breast and gynecologic cancers.Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes.Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancerTopical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study.A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors.Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial.Diet and breast cancer prognosis: making sense of the Women's Healthy Eating and Living and Women's Intervention Nutrition Study trialsDietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trialIncreased depression and metabolic risk in postmenopausal breast cancer survivorsPromoting weight loss through diet and exercise in overweight or obese breast cancer survivors (InForma): study protocol for a randomized controlled trial.Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivorsDietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study.Longitudinal biological exposure to carotenoids is associated with breast cancer-free survival in the Women's Healthy Eating and Living Study.Dietary fat, tamoxifen use and circulating sex hormones in postmenopausal breast cancer survivors.Endogenous estradiol is not associated with poor physical health in postmenopausal breast cancer survivors.Nutrition and physical activity guidelines for cancer survivors.Ovarian cysts during tamoxifen use may affect the prognostic markers of premenopausal breast cancer.Diet and breast cancer: understanding risks and benefits.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Testosterone and risk of breast cancer: appraisal of existing evidence.Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.Associations of sex steroid hormones with mortality in women with breast cancer.The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer.Consumption of animal products, their nutrient components and postmenopausal circulating steroid hormone concentrations.
P2860
Q24187203-BC08DFD5-CD19-43C4-A883-DFD22295BC31Q24187985-064F6BAB-507E-4C60-A6D6-7E4B570F3C56Q24197817-0720EF45-55BB-4850-A1E8-89CE6A9FA10BQ24235559-152E05E9-8678-41A9-BFD0-3BF2468762D8Q28073413-62A4943C-C191-4355-8356-2C967C7A61D1Q30572730-EDFD0CA9-36D3-4D2E-AD7A-DB258F1894AAQ33587216-715EE39E-BAF2-400F-909A-575427D63C5CQ33611502-0F986EED-FEC1-4E6C-A908-ADC40049074BQ33686719-0614F2D1-7D45-4621-944D-C7ED1BF322CAQ33956785-301B88D4-C073-459F-9437-D17F09F39B36Q34065198-54D40A58-796F-4DD8-8DC8-6F819A9B88CCQ34129238-16BD8F44-67E4-44BF-AA97-370818D264DCQ34131967-A8ECBAAB-2530-4BD1-A586-F6F6BE96D4ADQ34949446-882ED9C9-70C4-4C9A-A8FB-9BE4D37B22DEQ35010154-42BE3A58-1D7E-4DF1-A063-406B3A449ADBQ35202833-6F9CEF89-172D-4332-AF35-A3D87F4E758BQ35584556-7B86ECDF-9AA7-4250-A910-370AE4DC4F44Q36443959-ED55450B-2C8A-4F30-91C1-ED6E5EDEAC3AQ36484937-203B4AAE-E4EA-464D-8DFF-CF27DDB537A5Q36672807-F60FDC01-748A-4CA5-8F17-68460EFCCC97Q37086324-A9D7D810-824F-4A32-9C05-316AA2FF748EQ37104757-F874928E-B09E-43DF-9FAA-BD308956A563Q37119419-C9F32985-41C7-42B0-A795-7BDFBB1298DCQ37133313-63A77F32-3939-4DC4-B8AA-45A710645CFCQ37170559-25D388E6-C3B3-4F06-99D0-8406DB4A964EQ37179165-B3B47D5B-A8FD-41F2-8A47-6ED0CBCC1EF4Q37194589-24D6AA60-B6EE-4D65-B19C-3EDCAB0A742EQ37355711-F269C5B0-3725-49DB-B583-AF8D98A3DC36Q37367134-E93A7E07-F49E-492F-B01E-FA0123A4A457Q38005959-AB2C0727-5AA5-4D4F-9EFE-FDD3C79DA582Q38027590-36071A11-2479-4668-9A25-8181D957B91CQ38040690-2121ECEA-8F9A-459A-91C9-E35BA85A8E19Q38097730-FC0A7E54-748C-449B-9B01-C17E6AB8E586Q38471436-919DB8ED-7C1F-4F38-9E2F-64D11258EA46Q38853194-31325F28-CC39-4EA8-AC1D-B379645C25DFQ39043672-D15A5403-9276-4D1A-8861-C458EC302445Q40006391-1D451FB7-E388-416C-A32D-F08855A8E904Q40110180-6016BD97-AB8B-4990-8120-1297C86FD940Q42378354-55BAFA3B-659D-4955-A86B-1442D8BFFA10Q43244689-98CCDEC6-A927-4C74-8783-FAFB0BA4A5C9
P2860
Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Reproductive steroid hormones ...... th a history of breast cancer.
@en
type
label
Reproductive steroid hormones ...... th a history of breast cancer.
@en
prefLabel
Reproductive steroid hormones ...... th a history of breast cancer.
@en
P2093
P2860
P1476
Reproductive steroid hormones ...... th a history of breast cancer.
@en
P2093
Cheryl L Rock
Cynthia A Thomson
Ellen B Gold
Frank Z Stanczyk
Gail A Laughlin
John P Pierce
Loki Natarajan
Lovell A Jones
Marcia L Stefanick
Richard A Hajek
P2860
P304
P356
10.1158/1055-9965.EPI-07-0761
P50
P577
2008-03-06T00:00:00Z